First Time Loading...

Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 3.85 USD 0.79% Market Closed
Updated: May 6, 2024

Harvard Bioscience Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Harvard Bioscience Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
WST
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Harvard Bioscience Inc
NASDAQ:HBIO
Revenue
$112.3m
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
West Pharmaceutical Services Inc
NYSE:WST
Revenue
$2.9B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
8%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

Harvard Bioscience Inc
Revenue Breakdown

Breakdown by Geography
Harvard Bioscience Inc

Total Revenue: 112.3m USD
100%
United States: 48.2m USD
42.9%
Europe: 32.8m USD
29.2%
Greater China: 18.5m USD
16.5%
Rest Of The World: 12.8m USD
11.4%
Show More
Show Less

Breakdown by Segments
Harvard Bioscience Inc

Total Revenue: 112.3m USD
100%
Instruments, Equipment, Software, And Accesso...: 105.7m USD
94.2%
Service, Maintenance, And Warranty Contracts: 6.5m USD
5.8%

See Also

What is Harvard Bioscience Inc's Revenue?
Revenue
112.3m USD

Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Revenue amounts to 112.3m USD.

What is Harvard Bioscience Inc's Revenue growth rate?
Revenue CAGR 10Y
1%

Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Harvard Bioscience Inc have been 3% over the past three years , -1% over the past five years , and 1% over the past ten years .